A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis

Wenyan Fu, Yu Liu, Fangjie Liu, Chenghua Liu, Jingjing Li, Jiali Niu, Peng Han, Dan Xu, Jiaojiao Hou, Yuanfang Ma, Jiannan Feng, Zhanguo Li, Rong Mu, Guang YangFrontiers in Immunology 2021 · DOI

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the production of multiple autoantibodies and frequent renal involvement, known as lupus nephritis (LN). The precise mechanisms driving LN development remain poorly understood. Bacterial biofilms, which protect bacteria from environmental stressors, are ubiquitous. This study identifies a conserved peptide (HU1) derived from DNABII proteins—a major component of bacterial biofilms—that is specifically recognized by the sera of approximately 47% of SLE patients. Serum anti-HU1 levels significantly correlate with the occurrence of LN. In a pristane-induced mouse model, the presence of anti-HU1 antibodies aggravated lupus nephritis, despite these antibodies also attenuating biofilm formation. Further investigation revealed that anti-HU1 antibodies cross-recognize protein disulfide isomerase (P4HB) on the renal cell surface, inhibiting its enzymatic activity. These findings uncover a novel mechanism of LN development triggered by molecular mimicry of bacterial biofilm components.

Introduction

Systemic lupus erythematosus (SLE) is a complex autoimmune condition where the immune system targets the body's own tissues. Lupus Nephritis (LN) is one of its most severe complications, leading to significant kidney inflammation and potential failure. While environmental triggers like bacterial infections are known to cause disease "flares," the specific molecular links between common infections and kidney injury have been unclear.

Bacteria often exist within biofilms—slimy, protective matrices that confer resistance to antibiotics and immune clearance. This research investigates whether conserved proteins within these biofilms act as "decoys," inducing the production of autoantibodies that mistakenly attack the host’s kidneys through molecular mimicry.

Methods and Materials

The researchers utilized a multi-disciplinary approach to link bacterial components to human pathology. They first identified highly conserved regions within the DNABII protein family, which is present in nearly all eubacteria. Using sequence alignment, they synthesized two specific peptides: HU1 and HU2.

Sequence alignment of DNABII proteins identifying conserved HU1 and HU2 domains.

The study involved a human serum cohort consisting of 103 SLE patients, 136 Rheumatoid Arthritis (RA) patients, 133 primary Systemic Sclerosis (pSS) patients, and 150 healthy controls (HC). Specific antibodies were detected using ELISA. To study the disease in vivo, a pristane-induced mouse model of SLE was employed, where mice were immunized with the HU1 peptide to observe its impact on renal outcomes. Molecular targets were identified using mass spectrometry and Western blotting, focusing on human proteins structurally similar to HU1.

Key Results

The study revealed that anti-HU1 antibodies are a significant marker for SLE and LN. Approximately 47% of SLE patients tested positive for anti-HU1, a significantly higher prevalence than in RA, pSS, or healthy control groups.

Prevalence of anti-HU1 and anti-HU2 antibodies across patient cohorts.

Key findings include:

  • Clinical Correlation: Elevated anti-HU1 levels strongly correlated with the presence of Lupus Nephritis and increased proteinuria, a hallmark of kidney damage.
  • In Vivo Aggravation: HU1-immunized mice exhibited more severe kidney pathology, including membrane thickening and increased immune complex deposition.
  • Molecular Mimicry and Enzymatic Inhibition: The anti-HU1 antibodies cross-react with human P4HB (Protein Disulfide Isomerase), an enzyme critical for protein folding and cell signaling. Functional assays demonstrated that these antibodies inhibit P4HB's reductase activity in a dose-dependent manner, disrupting renal cell homeostasis.

Discussion

This research highlights a "double-edged sword" immune response. While anti-HU1 antibodies can reduce bacterial biofilm formation, they simultaneously aggravate renal damage by attacking P4HB. This molecular mimicry provides a clear link between common bacterial exposures and the progression of autoimmune kidney disease.

The high specificity of anti-HU1 for SLE suggests its potential as a diagnostic biomarker for renal risk. However, the study is limited by its correlative nature in humans and the fact that 53% of SLE patients do not possess these specific antibodies, indicating other triggers are also at play. Future work should focus on the downstream signaling pathways—potentially involving ADAM17—and explore therapeutic strategies to protect P4HB or mask the HU1 epitope to mitigate kidney damage.

Summary updated

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with multiple autoantibody production and often affects the kidneys, known as lupus nephritis. However, the mechanism underlying lupus nephritis development is unclear. Biofilms that protect bacteria from stress are ubiquitous in almost every environment. Here, we identified that a conserved peptide (HU1) derived from DNABII proteins, one of major bacterial biofilm components, was specifically recognized by sera from about 47% patients with SLE. Moreover, the serum anti-HU1 levels showed a significant positive correlation with lupus nephritis occurrence. Presence of antibodies against HU1 in pristane-induced mice aggravated lupus nephritis, although these antibodies also attenuated bacterial biofilm formation. We further identified that antibodies against HU1 cross-recognized protein disulfide isomerase (P4HB) located on the renal cell surface and inhibited the activities of this enzyme. Our findings reveal a novel mechanism underlying the development of lupus nephritis triggered by bacterial biofilms.
BibTeX
@inproceedings{fu2021novel,
  author = {Wenyan Fu and Yu Liu and Fangjie Liu and Chenghua Liu and Jingjing Li and Jiali Niu and Peng Han and Dan Xu and Jiaojiao Hou and Yuanfang Ma and Jiannan Feng and Zhanguo Li and Rong Mu and Guang Yang},
  title = {{A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis}},
  booktitle = {Frontiers in Immunology},
  year = {2021},
  doi = {10.3389/fimmu.2021.656090},
}
Figure